Age-Related Macular Degeneration (AMD) Therapeutics Market Report

Global and Region Age-Related Macular Degeneration (AMD) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：208
  • REPORT CODE：GMM949373
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Age-Related Macular Degeneration (AMD) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Age-Related Macular Degeneration (AMD) Therapeuticsmarket, defines the market attractiveness level of Age-Related Macular Degeneration (AMD) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Age-Related Macular Degeneration (AMD) Therapeutics industry, describes the types of Age-Related Macular Degeneration (AMD) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Age-Related Macular Degeneration (AMD) Therapeutics market and the development prospects and opportunities of Age-Related Macular Degeneration (AMD) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Age-Related Macular Degeneration (AMD) Therapeutics market in Chapter 13.

    By Player:

    • Regeneron Pharmaceuticals Inc

    • Novartis AG

    • Bausch Health Companies Inc

    • F Hoffmann-La Roche Ltd

    • Amgen Inc

    By Type:

    • Wet AMD

    • Dry AMD

    By End-User:

    • Hospital

    • Clinic

    • Research Institute

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Age-Related Macular Degeneration (AMD) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Age-Related Macular Degeneration (AMD) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Age-Related Macular Degeneration (AMD) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Age-Related Macular Degeneration (AMD) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Age-Related Macular Degeneration (AMD) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption (2017-2022)

    • 7.2 United States Age-Related Macular Degeneration (AMD) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Consumption (2017-2022)

    • 7.4 China Age-Related Macular Degeneration (AMD) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Age-Related Macular Degeneration (AMD) Therapeutics Consumption (2017-2022)

    • 7.6 India Age-Related Macular Degeneration (AMD) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Age-Related Macular Degeneration (AMD) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Age-Related Macular Degeneration (AMD) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast (2022-2028)

    9 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Wet AMD Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dry AMD Consumption and Growth Rate (2017-2022)

    • 9.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Institute Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Wet AMD Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Dry AMD Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Institute Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Age-Related Macular Degeneration (AMD) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Competitive Analysis

    • 14.1 Regeneron Pharmaceuticals Inc

      • 14.1.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.1.2 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • 14.2 Novartis AG

      • 14.2.1 Novartis AG Company Details

      • 14.2.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • 14.3 Bausch Health Companies Inc

      • 14.3.1 Bausch Health Companies Inc Company Details

      • 14.3.2 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • 14.4 F Hoffmann-La Roche Ltd

      • 14.4.1 F Hoffmann-La Roche Ltd Company Details

      • 14.4.2 F Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 F Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • 14.5 Amgen Inc

      • 14.5.1 Amgen Inc Company Details

      • 14.5.2 Amgen Inc Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Amgen Inc Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Age-Related Macular Degeneration (AMD) Therapeutics

    • Figure Age-Related Macular Degeneration (AMD) Therapeutics Picture

    • Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Age-Related Macular Degeneration (AMD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Age-Related Macular Degeneration (AMD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Wet AMD Consumption and Growth Rate (2017-2022)

    • Figure Global Dry AMD Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institute Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Wet AMD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dry AMD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institute Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Age-Related Macular Degeneration (AMD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Age-Related Macular Degeneration (AMD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • Table Bausch Health Companies Inc (Foundation Year, Company Profile and etc.)

    • Table Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Companies Inc Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Therapeutics Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Age-Related Macular Degeneration (AMD) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US